DENTSPLY SIRONA (XRAY) 44th Annual J.P. Morgan Healthcare Conference summary
Event summary combining transcript, slides, and related documents.
44th Annual J.P. Morgan Healthcare Conference summary
14 Jan, 2026Leadership and Strategic Vision
New CEO with extensive medtech experience is driving a turnaround, supported by new leadership appointments including a Chief Commercial Officer, US commercial head, interim CFO, and board members with dental market expertise.
Focus on brand strength, customer loyalty, and an integrated portfolio to shape the future of connected dentistry.
Creation of a Growth and Value (Creation) Committee/Board to guide long-term strategy, capital allocation, and potential portfolio moves.
Emphasis on urgent execution, operational change, and embedded accountability to address underperformance and drive growth.
Ongoing commitment to provide updates as milestones are achieved.
Market Position and Portfolio
Operates in over 100 countries, reaching 400,000+ practitioners annually through training, and serves a $33 billion total addressable market growing 3%-4% annually.
Holds leading positions in chairside, imaging, endodontics, and preventive dental solutions, with over 50 new products launched in four years.
Integrated portfolio spans essential dental, orthodontic, implant, and connected technology solutions, with DS Core platform central to connected dentistry strategy.
Wellspect business retained for its cash flow contribution and is now managed independently.
Connected dentistry strategy leverages technology to streamline workflows and enhance patient-centered care.
Customer-Centric and Innovation Initiatives
Shift to a customer-centric mindset, including KOL boards for each segment and doubling clinical education investment to $40 million.
Enhanced dentist engagement in R&D, increased sales force education, and expanded dealer networks to improve product fit and market engagement.
Accelerated R&D investment, targeting a rise from 4% to 6% of sales, with double-digit R&D growth over 24 months focused on DS Core, implants, and orthodontics.
AI and data analytics initiatives to drive efficiency, faster decision-making, and predictive business moves.
DS Core platform enables integration with third-party labs and equipment, supporting comprehensive workflows.
Latest events from DENTSPLY SIRONA
- Turnaround strategy centers on execution, innovation, and targeted investments for long-term growth.XRAY
Leerink Global Healthcare Conference 202610 Mar 2026 - Q4 2025 sales rose but FY 2025 declined; restructuring and dividend cut shift focus to growth.XRAY
Q4 202527 Feb 2026 - All proposals, including director elections and incentive plan amendment, were approved by majority vote.XRAY
AGM 20253 Feb 2026 - Transformation and digitalization drive growth, but implants continue to underperform.XRAY
43rd Annual J.P. Morgan Healthcare Conference 20253 Feb 2026 - Q2 sales fell 4.2% to $984M, with a net loss and new cost-saving restructuring underway.XRAY
Q2 20242 Feb 2026 - Transformation and digitalization target $200M+ savings and 500 bps margin growth by 2026.XRAY
The 44th Annual William Blair Growth Stock Conference1 Feb 2026 - Primescan 2 launch and operational streamlining drive digital growth amid muted dental demand.XRAY
Morgan Stanley 22nd Annual Global Healthcare Conference22 Jan 2026 - Digital transformation and cloud innovation drive growth amid ongoing restructuring and market shifts.XRAY
Baird's 2024 Global Healthcare Conference21 Jan 2026 - Q3 sales rose 1.3%, but Byte suspension and a $495M impairment drove a $494M net loss.XRAY
Q3 202416 Jan 2026